Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.97%
Change (1 year)
Categories
Cerus (CERS) Fails to deliver data
Key failure to deliver metrics for Cerus:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.09 M
- Last year FTD volume: $1.84 M
Failures to deliver for Cerus (CERS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cerus (CERS) - since 2013
Volume in USD (price x number of shares), data since 2013Cerus (CERS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.09 M | -96.27% |
| 2023 | $2.52 M | -24.49% |
| 2022 | $3.34 M | -55.63% |
| 2021 | $7.53 M | 15.8% |
| 2020 | $6.51 M | 146.78% |
| 2019 | $2.63 M | 19.35% |
| 2018 | $2.21 M | -32.13% |
| 2017 | $3.25 M | -68.23% |
| 2016 | $10.25 M | -45.61% |
| 2015 | $18.84 M | 15.7% |
| 2014 | $16.29 M | 664.06% |
| 2013 | $2.13 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Boston Scientific BSX | $65.42 M | $0.10 B | 🇺🇸 USA |
 Utah Medical Products UTMD | $1.59 M | $2.63 M | 🇺🇸 USA |
 Haemonetics HAE | $8.76 M | $11.73 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.05 M | $0.25 M | 🇺🇸 USA |